307 related articles for article (PubMed ID: 25800274)
1. CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.
Novais FO; Scott P
Semin Immunopathol; 2015 May; 37(3):251-9. PubMed ID: 25800274
[TBL] [Abstract][Full Text] [Related]
2. Phenotyping of circulating CD8⁺ T cell subsets in human cutaneous leishmaniasis.
Khamesipour A; Nateghi Rostami M; Tasbihi M; Miramin Mohammadi A; Shahrestani T; Sarrafnejad A; Sohrabi Y; Eskandari SE; Keshavarz Valian H
Microbes Infect; 2012 Aug; 14(9):702-11. PubMed ID: 22421108
[TBL] [Abstract][Full Text] [Related]
3. CD8 cytotoxic T cells in cutaneous leishmaniasis.
Ruiz JH; Becker I
Parasite Immunol; 2007 Dec; 29(12):671-8. PubMed ID: 18042173
[TBL] [Abstract][Full Text] [Related]
4. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
Ritter U; Meissner A; Scheidig C; Körner H
Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes.
Amit A; Dikhit MR; Mahantesh V; Chaudhary R; Singh AK; Singh A; Singh SK; Das VN; Pandey K; Ali V; Narayan S; Sahoo GC; Das P; Bimal S
J Biomol Struct Dyn; 2017 Jan; 35(1):128-140. PubMed ID: 26727289
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.
Hwang S; Khan IA
Semin Immunopathol; 2015 May; 37(3):271-9. PubMed ID: 25944514
[TBL] [Abstract][Full Text] [Related]
7. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells.
Kima PE; Ruddle NH; McMahon-Pratt D
J Immunol; 1997 Aug; 159(4):1828-34. PubMed ID: 9257846
[TBL] [Abstract][Full Text] [Related]
8. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
[TBL] [Abstract][Full Text] [Related]
9. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain.
Landrith TA; Harris TH; Wilson EH
Semin Immunopathol; 2015 May; 37(3):261-70. PubMed ID: 25898888
[TBL] [Abstract][Full Text] [Related]
11. [Immunopathology of American tegumentary leishmaniasis].
Castés M; Tapia FJ
Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
[TBL] [Abstract][Full Text] [Related]
12. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires.
Uyemura K; Pirmez C; Sieling PA; Kiene K; Paes-Oliveira M; Modlin RL
J Immunol; 1993 Dec; 151(12):7095-104. PubMed ID: 7903101
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.
Ferraz R; Cunha CF; Gomes-Silva A; Schubach AO; Pimentel MI; Lyra MR; Mendonça SC; Valete-Rosalino CM; Da-Cruz AM; Bertho ÁL
BMC Infect Dis; 2015 Feb; 15():74. PubMed ID: 25870976
[TBL] [Abstract][Full Text] [Related]
14. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis.
Antonelli LR; Dutra WO; Oliveira RR; Torres KC; Guimarães LH; Bacellar O; Gollob KJ
Infect Immun; 2006 Nov; 74(11):6317-23. PubMed ID: 16923794
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
Erb K; Blank C; Ritter U; Bluethmann H; Moll H
Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
[TBL] [Abstract][Full Text] [Related]
16. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis.
Wang ZE; Reiner SL; Hatam F; Heinzel FP; Bouvier J; Turck CW; Locksley RM
J Immunol; 1993 Aug; 151(4):2077-86. PubMed ID: 8102158
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology.
Gollob KJ; Antonelli LR; Faria DR; Keesen TS; Dutra WO
Int Immunopharmacol; 2008 Oct; 8(10):1338-43. PubMed ID: 18687296
[TBL] [Abstract][Full Text] [Related]
18. Regulator and effector functions of T-cell subsets in human Leishmania infections.
Kemp M
APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
[TBL] [Abstract][Full Text] [Related]
19. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous leishmaniasis: immune responses in protection and pathogenesis.
Scott P; Novais FO
Nat Rev Immunol; 2016 Sep; 16(9):581-92. PubMed ID: 27424773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
